Events
2023 Business Group on Health Annual Conference

Find us at BGoH in Washington DC on April 26-28 to discuss how we can help you improve member heart health and reduce healthcare costs. We look forward to seeing you!

Homepage Hero image

No items found.
No items found.

Bookmark our Panel Session

Heart Disease, Too Long at the Top

Date:
Sunday, October 8
Time:
2:00 PM—2:40 PM PDT
Maayan Cohen
Co-Founder & CEO, Hello Heart

RSVP for our Special Event

Washington, DC

Skylines & Solutions: A Night Of Networking In Our Nation’s Capital

April 27, 2023

7:00 pm

RSVP
View all

Not going to BGoH Annual Conference but want to learn more?

Looking for user help? Get support here

Contact us

Email us at support@helloheart.com
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
We protect your information. Take a look at our Privacy Policy
Footnotes
  1. Gazit T, Gutman M, Beatty AL. Assessment of Hypertension Control Among Adults Participating in a Mobile Technology Blood Pressure Self-management Program. JAMA Netw Open. 2021;4(10):e2127008, https://doi.org/10.1001/jamanetworkopen.2021.27008. Accessed May 23, 2022. (Some study authors are employed by Hello Heart. Because of the observational nature of the study, causal conclusions cannot be made. There were 108 participants with baseline blood pressure over 140/90 who had been enrolled in the program for 3 years and had application activity during weeks 148-163. See additional important study limitations in the publication.)
  2. Sources: (1) Gazit T, Gutman M, Beatty AL. Assessment of Hypertension Control Among Adults Participating in a Mobile Technology Blood Pressure Self-management Program. JAMA Netw Open. 2021;4(10):e2127008, https://doi.org/10.1001/jamanetworkopen.2021.27008. Accessed May 23, 2022. (Some study authors are employed by Hello Heart. Because of the observational nature of the study, causal conclusions cannot be made. See additional important study limitations in the publication. This study showed that 108 participants with baseline blood pressure over 140/90 who had been enrolled in the program for 3 years and had application activity during weeks 148-163 were able to reduce their blood pressure by 21 mmHg using the Hello Heart program.) (2) Livongo Health, Inc. Form S-1 Registration Statement. https://www.sec.gov/Archives/edgar/data/1639225/000119312519185159/d731249ds1.htm. Published June 28, 2019. Accessed May 23, 2022. (In a pilot study that lasted six weeks, individuals starting with a blood pressure of greater than 140/90 mmHg, on average, had a 10 mmHG reduction.) NOTE: This comparison is not based on a head-to-head study, and the difference in results may be due in part to different study protocols.
  3. Gazit T, Gutman M, Beatty AL. Assessment of Hypertension Control Among Adults Participating in a Mobile Technology Blood Pressure Self-management Program. JAMA Netw Open. 2021;4(10):e2127008, https://doi.org/10.1001/jamanetworkopen.2021.27008. Accessed May 23, 2022. (Some study authors are employed by Hello Heart. Because of the observational nature of the study, causal conclusions cannot be made. There were 495 participants with baseline systolic blood pressure of 120-129 mmHg who had been enrolled in the program for 1 year and had application activity during weeks 48-55. There were 258 participants with baseline systolic blood pressure of 120-129 mmHg who had been enrolled in the program for 2 years and had application activity during weeks 96-111. There were 83 participants with baseline systolic blood pressure of 120-129 mmHg who had been enrolled in the program for 3 years and had application activity during weeks 148-163. See additional important study limitations in the publication.)
  4. Gazit T, Gutman M, Beatty AL. Assessment of Hypertension Control Among Adults Participating in a Mobile Technology Blood Pressure Self-management Program. JAMA Netw Open. 2021;4(10):e2127008, https://doi.org/10.1001/jamanetworkopen.2021.27008. Accessed May 23, 2022. (Some study authors are employed by Hello Heart. Because of the observational nature of the study, causal conclusions cannot be made. There were 673 participants with baseline systolic blood pressure of 130-139 mmHg who had been enrolled in the program for 1 year and had application activity during weeks 48-55. There were 318 participants with baseline systolic blood pressure of 130-139 mmHg who had been enrolled in the program for 2 years and had application activity during weeks 96-111. There were 99 participants with baseline systolic blood pressure of 130-139 mmHg who had been enrolled in the program for 3 years and had application activity during weeks 148-163. See additional important study limitations in the publication.)
  5. Gazit T, Gutman M, Beatty AL. Assessment of Hypertension Control Among Adults Participating in a Mobile Technology Blood Pressure Self-management Program. JAMA Netw Open. 2021;4(10):e2127008, https://doi.org/10.1001/jamanetworkopen.2021.27008. Accessed May 23, 2022. (Some study authors are employed by Hello Heart. Because of the observational nature of the study, causal conclusions cannot be made. There were 1,074 participants with baseline blood pressure over 140/90 who had been enrolled in the program for 1 year and had application activity during weeks 48-55. There were 419 participants with baseline blood pressure over 140/90 who had been enrolled in the program for 2 years and had application activity during weeks 96-111. There were 108 participants with baseline blood pressure over 140/90 who had been enrolled in the program for 3 years and had application activity during weeks 148-163. See additional important study limitations in the publication.)
  6. Kaplan AL, Cohen ER, Zimlichman E. Improving patient engagement in self-measured blood pressure monitoring using a mobile health technology. Health Inf Sci Syst. 2017; 5 (4). https://doi.org/10.1007/s13755-017-0026-9. Accessed May 23, 2022 (Because of the observational nature of the study, causal conclusions cannot be made. There were 783 participants with baseline systolic blood pressure ≥ 140. See additional important study limitations in the publication.)
  7. Surgeon General’s Call to Action to Control Hypertension. CDC Web site. https://www.cdc.gov/bloodpressure/docs/SG-CTA-HTN-Control-Report-508.pdf. Published 2020. Accessed May 23, 2022.
  8. Ettehad D, Emdin CA, Kiran A, Anderson SG, Callender T, Emberson J, et al. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet. 2016;387(10022):957-967. https://doi.org/10.1016/S0140-6736(15)01225-8. Accessed May 23, 2022.
  9. Validation Institute. 2021 Validation Report (Valid Through October 2022). https://validationinstitute.com/wp-content/uploads/2021/10/Hello_Heart-Savings-2021-Final.pdf. Published October 2021. Accessed May 23, 2022. (This analysis was commissioned by Hello Heart, which provided a summary report of self-funded employer client medical claims data for 203 Hello Heart users and 200 non-users from 2017-2020. Findings have not been subjected to peer review.)
  10. Depends on employer size. Based on data on file at Hello Heart. Results may differ from employer to employer.
  11. While the data featured here reflects a real user, the person shown in the photograph is a model and is not an actual user of, nor affiliated with, Hello Heart.